Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Smooth Muscle Cell-Specific Txnip Deficiency Ameliorates Vascular Calcification

View through CrossRef
Vascular calcification is a significant pathological characteristic of cardiovascular diseases, often exacerbated by metabolic disorders such as chronic kidney disease and diabetes mellitus. Recent studies have highlighted oxidative stress and inflammation as central mechanisms in the development of vascular calcification. While TXNIP is known to positively regulate reactive oxygen species (ROS) generation and inflammasome activation, the specific contributions of TXNIP to vascular calcification have not been thoroughly elucidated. This study aimed to elucidate the role of TXNIP in the pathogenesis of vascular calcification through combined in vitro and in vivo approaches. In murine models of a 5/6 nephrectomy mouse model and a vitamin D3-induced mouse model with nephropathy, TXNIP gene expression was elevated. Additionally, our results demonstrate that heightened TXNIP expression in vascular smooth muscle cells, triggered by factors like hyperphosphatemia and vitamin D3, correlates with increased calcification. This association is evidenced by elevated calcium deposition, upregulation of osteogenic markers, and enhanced mitochondrial-derived ROS production. In contrast, targeted genetic modifications to induce TXNIP deficiency in smooth muscle cells significantly mitigate these effects. Specifically, TXNIP knockout mice exhibited reduced vascular calcification, decreased ROS generation, and lower expression of osteogenic differentiation markers compared to their wild-type counterparts. Moreover, suppression of TXNIP in these models inhibited inflammasome activation and mitochondrial dysfunction, suggesting a novel linkage between TXNIP activity and osteogenic differentiation pathways in vascular calcification. The insights from this comprehensive study indicate that TXNIP not only amplifies oxidative stress and inflammation in vascular cells but also represents a potential therapeutic target for mitigating vascular calcification. Modulating TXNIP expression or function may reduce the incidence of vascular calcification in patients with cardiovascular diseases linked to metabolic disorders.
Title: Smooth Muscle Cell-Specific Txnip Deficiency Ameliorates Vascular Calcification
Description:
Vascular calcification is a significant pathological characteristic of cardiovascular diseases, often exacerbated by metabolic disorders such as chronic kidney disease and diabetes mellitus.
Recent studies have highlighted oxidative stress and inflammation as central mechanisms in the development of vascular calcification.
While TXNIP is known to positively regulate reactive oxygen species (ROS) generation and inflammasome activation, the specific contributions of TXNIP to vascular calcification have not been thoroughly elucidated.
This study aimed to elucidate the role of TXNIP in the pathogenesis of vascular calcification through combined in vitro and in vivo approaches.
In murine models of a 5/6 nephrectomy mouse model and a vitamin D3-induced mouse model with nephropathy, TXNIP gene expression was elevated.
Additionally, our results demonstrate that heightened TXNIP expression in vascular smooth muscle cells, triggered by factors like hyperphosphatemia and vitamin D3, correlates with increased calcification.
This association is evidenced by elevated calcium deposition, upregulation of osteogenic markers, and enhanced mitochondrial-derived ROS production.
In contrast, targeted genetic modifications to induce TXNIP deficiency in smooth muscle cells significantly mitigate these effects.
Specifically, TXNIP knockout mice exhibited reduced vascular calcification, decreased ROS generation, and lower expression of osteogenic differentiation markers compared to their wild-type counterparts.
Moreover, suppression of TXNIP in these models inhibited inflammasome activation and mitochondrial dysfunction, suggesting a novel linkage between TXNIP activity and osteogenic differentiation pathways in vascular calcification.
The insights from this comprehensive study indicate that TXNIP not only amplifies oxidative stress and inflammation in vascular cells but also represents a potential therapeutic target for mitigating vascular calcification.
Modulating TXNIP expression or function may reduce the incidence of vascular calcification in patients with cardiovascular diseases linked to metabolic disorders.

Related Results

Molecular mechanisms of cellular control through the TXNIP protein
Molecular mechanisms of cellular control through the TXNIP protein
<p dir="ltr">The thioredoxin-interacting protein (TXNIP) is a unique member of the a-arrestin family, as it is the only arrestin identified as an endogenous inhibitor of thio...
Molecular mechanisms of cellular control through the TXNIP protein
Molecular mechanisms of cellular control through the TXNIP protein
<p dir="ltr">The thioredoxin-interacting protein (TXNIP) is a unique member of the a-arrestin family, as it is the only arrestin identified as an endogenous inhibitor of thio...
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
Objectives Aim: To observe aortic and cardiac aldosterone expression and its receptor changes in rats with vascular calcification, and exogenous aldosterone effec...
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives: Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substanti...
Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention
Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention
Background: Diabetes mellitus (DM) is a common metabolic disorder characterized by a persistent increment of blood glucose. Type 2 DM is characterized by insulin resistance and β-c...
P1642CORONARY ARTERY CALCIFICATION AMONG RENAL TRANSPLANT RECIPIENTS
P1642CORONARY ARTERY CALCIFICATION AMONG RENAL TRANSPLANT RECIPIENTS
Abstract Background and Aims Bone-mineral disease and vascular calcification are common complications in hemodialysis. The harmo...
TXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding
TXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding
Abstract c-Myc protooncogene places a demand on glucose uptake to drive glucose-dependent biosynthetic pathways. To achieve thi...
Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK
Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK
<i>Background:</i> Mönckeberg’s calcification in diabetes, known as medial artery calcification, is an independent predictor of cardiovascular mortality. However, the m...

Back to Top